Vintura

based in the Netherlands, advises life-sciences clients on policy shaping and commercial strategy across European reimbursement systems, addressing the persistent gap between what a device can offer and what patients actually receive under national coverage decisions.

国家
Netherlands
EU
覆盖范围
EUUS
regulatory-legal✓✓
监管机构fda
技术
名称集群风险
医疗器械医保报销准入regulatory-legal低→

由 BIOECON 依据一手资料编制。

合规 Bioecon 是信息中介,并非监管机构、认证机构或法律顾问。在与公共部门客户合作时 (依据 44-FZ / 223-FZ 的采购),Bioecon 仅作为独立分析平台,不收取供应商任何报酬。